Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts
Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced […]
Koa Health Bolsters UK Leadership Team Appointing First UK Commercial Director as Business Grows
Koa Health, a digital mental healthcare provider offering personalized mental health solutions backed by science, […]
Obsidian Therapeutics Appoints Maria Fardis, Ph.D., to Board of Directors
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced the […]
Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Gastrointestinal Business
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., […]
Elevation Oncology Announces the Promotion of Valerie Malyvanh Jansen, M.D., Ph.D., to Chief Medical Officer
Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision […]
Targovax ASA Appoints Dr. Erik Digman Wiklund as New CEO
Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL
Illumina, Inc. (NASDAQ:ILMN) today announced that Bob Ragusa has been appointed as Chief Executive Officer of GRAIL, […]
SAGA Diagnostics Appoints Peter Collins as Chief Executive Officer
SAGA Diagnostics AB (“SAGA”), a leading cancer liquid biopsy and genomic testing company, has announced the […]
Capital Rx Adds Chief Financial Officer with Health Plan Experience
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are […]
Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer
Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more